1. Saint Martin MJ, Frouin F, Malhaire C, Orlhac F. Decrypting the information captured by MRI-radiomic features in predicting the response to neoadjuvant chemotherapy in breast cancer. 44th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC), 3227-3230, 2022. DOI: 10.1109/EMBC48229.2022.9871844.
  2. Thomas CD, Lupu M, Poyer F, Maillard P, Mispelter J. Increased PDT efficacy when associated with nitroglycerin: a study of retinoblastoma xenografts on mice. Pharmaceuticals, 15(8):985, 2022. DOI: 10.3390/ph15080985

  3. Beddok A, Saint-Martin C, Ala Eddine C, Champion L, Krhili S, Chilles A, Catteau L, Goudjil F, Zefkili S, Amessis M, Peurien D, Choussy O, Le Tourneau C, Klijanienko J, Dendale R, Buvat I , Créhange G, Calugaru V. Curative high-dose reirradiation for patients with recurrent head and neck squamous cell carcinoma using IMRT or proton therapy: Outcomes and Analysis of patterns of failure. Head & Neck, 44(11):2452-2464, 2022. DOI: 10.1002/hed.27153
  4. Beddok A, Guzene L, Coutte A, Thomson D, Yom SS, Calugaru V, Blais E, Gilliot O, Racadot S, Pointreau Y, Corry J, Jensen K, Porceddu S, Khalladi N, Bastit V, Lasne-Cardon A, Marcy PY, Carsuzaa F, Nioche C, Bourhis J, Salleron J, Thariat J; GORTEC. International assessment of interobserver reproducibility of flap delineation in head and neck carcinoma. Acta Oncol. 61(6):672-679, 2022. DOI: 10.1080/0284186X.2022.2036367.

  5. Guzene L, Beddok A, Nioche C, Modzelewski R, Loiseau C, Salleron J, Thariat J. Assessing Interobserver Variability in the Delineation of Structures in Radiation Oncology: A Systematic Review. Int J Radiat Oncol Biol Phys. S0360-3016(22)03551-9, 2022. DOI: 10.1016/j.ijrobp.2022.11.021.

  6. Beddok A, Lahaye C, Calugaru V, De Marzi L, Fouillade C, Salvador S, Fontbonne JM, Favaudon V, Thariat J. A Comprehensive Analysis of the Relationship Between Dose Rate and Biological Effects in Preclinical and Clinical Studies, From Brachytherapy to Flattening Filter Free Radiation Therapy and FLASH Irradiation. Int J Radiat Oncol Biol Phys. 113(5):985-995, 2022. DOI: 10.1016/j.ijrobp.2022.02.009
  7. Porte J, Saint-Martin C, Frederic-Moreau T, Massiani MA, Bozec L, Cao K, Verrelle P, Otz J, Jadaud E, Minsat M, Langer A, Girard N, Créhange G, Beddok A. Efficacy and Safety of Combined Brain Stereotactic Radiotherapy and Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with Brain Metastases. Biomedicines. 10(9):2249, 2022. DOI: 10.3390/biomedicines10092249

  8. Beddok A, Scher N, Alapetite C, Baussart B, Bentahila G, Bielle F, Bolle S, Dendale R, Dureau S, Goudjl F, Helfre S, Mammar H, Nichelli L, Calugaru V, Feuvret L. Protontherapy for adult craniopharyngioma: experience of a single institution in 91 consecutive patients. Neuro Oncol. In press, 2022. DOI: 10.1093/neuonc/noac210

  9. Beddok A, Chabi-Charvillat ML, Kennel T, de Wolf J, Pricopi C, Crequit P, Girard N, Otz J, Vallée A, Longchampt E, Sage E, Glorion M. Prospective Radiologic-Pathologic Correlation of Macroscopic Volume and Microscopic Extension of Nonsolid Lung Nodules on Thin-section CT Images for Sublobar Resection and Stereotactic Radiotherapy Planning. Clin Lung Cancer. 2022 Nov 9:S1525-7304(22)00243-1. DOI: 10.1016/j.cllc.2022.11.001.

  10. Bauer J, Hildebrandt M, Baumgartl M, Fiedler F, Robert C, Buvat I,  Enghardt W, Parodi K. Quantitative assessment of radionuclide production yields in in-beam and offline PET measurements at different proton irradiation facilities. Phys Med Biol, 14;67(15). DOI : 10.1088/1361-6560/ac7a89.

  11. Durmo R, Donati B, Rebaud L, Cottereau AS, Ruffini A, Nizzoli M, Ciavarella S, Vegliante M, Nioche C, Meignan M, Merli F, Versari A, Ciarrocchi A, Buvat I, Luminari S. Prognostic value of lesion dissemination in ABVD-treated, iPET-negative cHL patients: a radio-genomic study. Hemat Oncol. 40(4):645-657, 2022. DOI: 10.1002/hon.3025 
  12. Jha AK, Bradshaw TJ, Buvat I, Hatt M, Kc P, Liu C, Obuchowski NF, Saboury B, Slomka PJ, Sunderland JJ, Wahl RL, Yu Z, Zuehlsdorff S, Rahmim A, Boellaard R. Nuclear Medicine and Artificial Intelligence: Best Practices for Evaluation (the RELAINCE guidelines). J Nucl Med. 63: 1288-1299, 2022. DOI: https://doi.org/10.2967/jnumed.121.263239 

  13. Guesdon-Vennerie A, Couvreur P, Ali F, Pouzoulet F, Roulin C, Martínez-Rovira I, Bernadat G, Legrand FX, Bourgaux C, Mazars C, Marco S, Trépout S, Mura S, Mériaux S, Bort G. Breaking photoswitch activation depth limit using ionising radiation stimuli adapted to clinical application. Nat Comm. 13(1):4102. DOI: 10.1038/s41467-022-30917-0

  14. Girum KB, Rebaud L, Cottereau AS, Meignan M, Clerc J, Vercellino L, Casasnovas O, Morschhauser F, Thieblemont C, Buvat I. 18F-FDG PET maximum intensity projections and artificial intelligence: a win-win combination to easily measure prognostic biomarkers in DLBCL patients. J Nucl Med 63(12):1925-1932, 2022. DOI :10.2967/jnumed.121.263501.

  15. Kolinger GD, García DV, Kramer GM, Frings V, Zwezerijnen GJC, Smit EF, De Langen AJ, Buvat I, Boellaard R. Effects of tracer uptake time in non-small cell lung cancer 18F-FDG PET radiomics. J Nucl Med. 63(6):919-924, 2022. DOI: 10.2967/jnumed.121.262660

  16. Comte V, Schmutz H, Humbert O, Orlhac F, Chardin D, Darcourt J. Development and validation of a radiomic model for the diagnosis of dopaminergic denervation on [18F]FDOPA PET/CT. Eur J Nucl Med Mol Imaging. 49(11):3787-3796. 2022. DOI: 10.1007/s00259-022-05816-7

  17. Peltier A, Seban R, Buvat I, Bidard FC, Mechta-Grigoriou F. Fibroblast heterogeneity in solid tumors: from single cell analysis to whole-body imaging. Semin Cancer Biol. 86(Pt3):262-272, 2022. DOI: 10.1016/j.semcancer.2022.04.008
  18. Dal Toso L, Chalampalakis Z, Buvat I, Comtat C, Cook G, Goh V, Schnabel JA, Marsden PK. Improved 3D Tumour Definition and Quantification of Uptake in Simulated Lung Tumours Using Deep Learning. Phys Med Biol. 67:095013, 2022. DOI: 10.1088/1361-6560/ac65d6

  19. Bradshaw TJ, Boellaard R, Dutta J, Jha AK, Jacobs P, Li Q, Liu C, Sitek A, Saboury B, Scott PJH, Slomka PJ, Sunderland JJ, Wahl RL, Yousefirizi F, Zuehlsdorff S, Rahmim A, Buvat I. Nuclear Medicine and Artificial Intelligence: Best Practices for Algorithm Development. J Nucl Med. 63(4):500-510, 2022. DOI: https://doi.org/10.2967/jnumed.121.262567 
  20. Créhange G, Goudjil F, Krhili SL, Minsat M, de Marzi L, Dendale R. The role of proton therapy in esophageal cancer. Cancer radiotherapie 26(4):602-610, 2022. DOI: https://doi.org/10.1016/j.canrad.2021.08.015

  21. Beddok A, Calugaru V, de Marzi L, Graff P, Dumas JL, Goudjil F, Dendale R, Minsat M, Verrelle P, Buvat I, Créhange G. Clinical and technical challenges of cancer reirradiation: Words of wisdom. Crit Rev Oncol Hematol. 174:103655, 2022. DOI: 10.1016/j.critrevonc.2022.103655

  22. Ortiz R, De Marzi L, Prezado Y. Proton Minibeam Radiation Therapy and Arc Therapy: Proof of Concept of a Winning Alliance. Cancers (Basel). 14(1):116, 2022. DOI: 10.3390/cancers14010116.

  23. Escobar T, Vauclin S, Orlhac F, Nioche C, Pineau P, Champion L, Brisse H, Buvat I. Voxel-wise supervised analysis of tumors with multimodal engineered features to highlight interpretable biological patterns. Med Phys. 49(6):3816-3829, 2022. DOI: 10.1002/mp.15603
  24. Wallis D, Buvat I. Clever Hans effect found in a widely used brain tumour MRI dataset. Med Image Anal. 77:102368, 2022. DOI: 10.1016/j.media.2022.102368

  25. Loap P, Mirandola A, De Marzi L, Vitolo V, Barcellini A, Iannalfi A, Dendale R, Kirova Y, Orlandi E. Cardiac conduction system exposure with modern radiotherapy techniques for mediastinal Hodgkin lymphoma irradiation (Letter). Acta Oncol. 11:1-4, 2022. DOI: 10.1080/0284186X.2021.2025265.

  26. Seban RD, Champion L, Muneer I, Synn S, Schwartz LH, Dercle L. Potential theranostic role of bone marrow glucose metabolism on baseline [18F]-FDG PET/CT in metastatic melanoma (letter to the Editor). J Nucl Med. 63:166, 2022. DOI: 10.2967/jnumed.121.262361
  27. Cardoen L, Tauziède-Espariat A, Dangouloff-Ros V, Moalla S, Nicolas N, Roux CJ, Bouchoucha Y, Bourdeaut F, Beccaria K, Bolle S, Pierron G, Dufour C, Doz F, Boddaert N, Brisse HJ. Imaging Features with Histopathologic Correlation of CNS High-Grade Neuroepithelial Tumors with a BCOR Internal Tandem Duplication. AJNR Am J Neuroradiol. 43:151-156, 2022. DOI: 10.3174/ajnr.A7367.

  28. Orlhac F, Eertink JJ, Cottereau AS, Zijlstra JM, Thieblemont C, Meignan M, Boellaard R, Buvat I. A guide to ComBat harmonization of imaging biomarkers in multi center studies. J Nucl Med. 63(2):172-179, 2022. DOI: https://doi.org/10.2967/jnumed.121.262464 
  29. Wallis D, Soussan M, Lacroix M, Akl P, Duboucher C, Buvat I. An FDG-PET/CT deep learning method for fully automated detection of pathological mediastinal lymph nodes in lung cancer patients. Eur J Nucl Med Mol Imaging. 49(3):881-888, 2022. DOI: https://doi.org/10.1007/s00259-021-05513-x

  30. Hahn C, Ödén J, Dasu A, Vestergaard A, Fuglsang Jensen M, Sokol O, Pardi C, Bourhaleb F, Leite A, de Marzi L, Smith E, Aitkenhead A, Rose C, Merchant M, Kirkby K, Grzanka L, Pawelke J, Lühr A. Towards harmonizing clinical linear energy transfer (LET) reporting in proton radiotherapy: a European multi-centric study. Acta oncologica, 61:206-214, 2022. DOI:  https://doi.org/10.1080/0284186X.2021.1992007

  31. Cavallone M, Prezado Y, De Marzi L. Converging Proton Minibeams with Magnetic Fields for Optimized Radiation Therapy: A Proof of Concept. Cancers (Basel). 14(1):26, 2022. DOI: 10.3390/cancers14010026

  32. Loap P, De Marzi L, Almeida CE, Barcellini A, Bradley J, de Santis MC, Dendale R, Jimenez R, Orlandi E, Kirova Y. Hadrontherapy techniques for breast cancer. Crit Rev Oncol Hematol. 169:103574, 2022. DOI: https://doi.org/10.1016/j.critrevonc.2021.103574.
  33. Perret P, Slimani L, Barone-Rochette G, Vollaire J, Briat A, Ahmadi M, Henri M, Desruet MD, Clerc R, Broisat A, Riou L, Boucher F, Frouin F, Djaileb L, Calizzano A, Vanzetto G, Fagret D, Ghezzi, C. Preclinical and clinical evaluation of a new method to assess cardiac insulin resistance using nuclear imaging. J Nucl Cardiol. 29:1419–1429, 2022. DOI: 10.1007/s12350-020-02520-7